期刊文献+

老年慢性阻塞性肺疾病患者血浆白细胞介素与干扰素-γ水平的相关性 被引量:1

Correlation between plasma levels of interleukin and interferon-γin elderly patients with chronic obstructive pulmonary disease
下载PDF
导出
摘要 目的:探讨老年慢性阻塞性肺疾病(chronicobstructivepulmonarydis-ease,COPD)患者血浆白细胞介素18(interleukin-18,IL-18)、IL-16,IL-4与干扰素-γ水平的相关性。方法:老年COPD患者共73例(重度21例,中度21例,轻度31例),正常对照31例。采用双抗体夹心酶联免疫吸附实验。检测其血浆IL-18,IL-16,IL-4,干扰素-γ水平。结果:①COPD患者(重、中、轻)急性期血浆IL-18水平(ng/L)分别为409.35±80.30,243.08±81.16,237.29±89.23,均明显高于对照组(139.40±43.74),差异有显著性意义(t=3.91,3.03,2.88,P均<0.01);IL-4水平分别为1.75±0.73,2.03±1.23,2.01±0.99,均明显低于对照组(3.08±1.25),差异有显著性意义(t=-4.78,-2.99,-3.68,P均<0.01);重度、中度组IL-16水平犤(270.60±90.78),(235.48±90.17)犦、干扰素-γ水平(ng/L)犤(11.05±4.55),(2.11±1.33)犦分别显著高于对照组犤(126.73±57.64),(1.03±0.51)犦,差异有显著性意义(t=6.95,6.17,10.05,3.71,P均<0.01)。②治疗后,各组(重、中、轻)缓解期血浆IL-18,IL-16、干扰素-γ水平均明显减低,差异有显著性意义(t=2.03~10.29,P均<0.01);重、轻度患者IL-4水平明显升高,差异有显著性意义(t=-5.86,-3.52,P均<0.01)。③急性期血浆中IL-18,IL-16。 AIM:To investigate the correlations of plasma levels of interleukin 18(IL 18),IL 16 and IL 4 with interferon γ(IFN γ) in elderly patients with chronic obstructive pulmonary disease(COPD). METHODS:A total of 73 elderly patients with COPD(21 severe,21 moderate and 31 mild) and 31 healthy controls were involved.The levels of IL 18,IL 16,IL 4 and IFN γwere detected with the double antibody sandwich enzyme linked immunoadsordent assay(ELISA). RESULTS:①At acute attack stage, the plasma levels of IL 18 of patients with severe,moderate and mild COPD were(409.35±80.30),(243.08±81.16) and(237.29±89.23) ng/L,respectively,all significantly higher than that in the control group[(139.40±43.74) ng/L](t=3.91,3.03,2.88,P< 0.01); and the IL 4 levels[(1.75±0.73),(2.03±1.23) and(2.01±0.99) ng/L,respectively] were significantly lower than that in the control group[(3.08±1.25) ng/L](t=-4.78,-2.99,-3.68,P< 0.01);The IL 16 levels[(270.60±90.78) and(235.48±90.17) ng/L] and the IFN γlevels[(11.05±4.55) and(2.11±1.33) ng/L] of the severe and moderate patients were significantly higher than those in the control group[(126.73±57.64) and(1.03±0.51) ng/L](t=6.95,6.17,10.05,3.71,P< 0.01).②At the remission stage after treatment,the plasma levels of IL 18,IL 16 and IFN γof the severe,moderate and mild patients were all obviously decreased with significantly differences(t=2.03-10.29,P< 0.01);and the IL 4 levels of severe and mild patients were increased obviously with significant differences(t=-5.86,-3.52,P< 0.01).③At acute attack stage of COPD,there were significant correlations among the plasma levels of IL 18,IL 16 and IFN γ(r=0.256-0.918,P< 0.05). CONCLUSION:COPD is characterized by a predominant expression of Th1 type cytokines in elderly patients.The elevated IL 18 and IL 16 levels may be associated with the increased secretion of IL 18 and IL 16 from mast cells.Monitoring the dynamic changes of plasma levels of IL 18 and IL 16 during the treatment of COPD may reflect the inflammatory conditions in the airways.
出处 《中国临床康复》 CAS CSCD 2004年第18期3520-3522,共3页 Chinese Journal of Clinical Rehabilitation
  • 相关文献

参考文献4

二级参考文献20

  • 1孙银香,阎启英,李长深,王甫,祝昌平,马广义,夏桂英.呼吸体操在肺心病和COPD缓解期的应用研究[J].中国康复医学杂志,1996,11(1):1-5. 被引量:18
  • 2蔡映云,王兴旗,吴振安,郑棣英,方宗君,钮善福.COPD 缓解期患者阈压力负荷吸气肌锻炼的疗效观察[J].中国康复医学杂志,1997,12(1):1-5. 被引量:8
  • 3方宗君,蔡映云,蒋浩明,王丽华,张国荣.COPD 的体外膈肌起搏远期疗效观察[J].中国康复医学杂志,1997,12(1):16-18. 被引量:10
  • 4Pesci A, Rossi GA, Bertorelli G, et al. Mast cells in the airway lunen and bronchial mucosa of patients with chronic bronchitis. Am J Respir Crit Care Med 1994;149:1311-6
  • 5Grashoff WF, Sont JK, Sterk PJ, et al. Chronic obstructive pulmonary disease role of bronchiolar mast cells and macrophages. Am J Patbol 1997; 151:1785-90
  • 6Rorke S, Holgate ST. Targeting adenosine receptors: novel therapeutic targets in asthma and chronic obstructive pulmonary disease. Am J Respir Med 2002; 1 (2):99-105
  • 7Holgate ST. The role of mast cells and basophils in inflammation. Clin Exp Allergy 2000; 30 Suppl 1: 28-32
  • 8He S, Peng Q, Walls AF. Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: Selective enhancement of eosinophil recuitment by histamine. J Immunol 1997; 159(12): 6216-25
  • 9He S, Walls AF. Human mast cell tryptase: a potent stimulus of microvascular leakage and mast cell activation. Eur J Pharmacol 1997; 382:89-97
  • 10He S, Aslam A, Gaca MD, et al. Inhibitors of Tryptase as Mast Cell Stabilising Agents in the Human Airways. Effects of Tryptase and Other Agonists of PAR2 on Histamine Release. J Pharmacol Exp Ther 2004; 13[Epub ahead of prin]

共引文献57

同被引文献28

  • 1王代红,袁发焕,张耀全.肥大细胞类胰蛋白酶对人肾成纤维细胞作用机制探讨[J].中华肾脏病杂志,2005,21(2):112-113. 被引量:1
  • 2Randall B, Butbs J, Halsey JF. Elevated postmortent tryptase in the absence of anaphylaxis[J]. J Forensic Sci, 1995, 40(2) : 208-211.
  • 3Cairns JA , Walls AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts [ J ] . J Clin Invest, 1997,99(6) : 1313-1321.
  • 4Sommerhoff CP. Mast cell tryptases and airway remodeling [ J ]. Am J Respir Crit Care Med,2001,164(10pt2) :S52-58.
  • 5Caughey GH. Mast cell tryptases and chymases in inflammation and host defense[ J]. Immunol Rev,2007,217 : 141-154.
  • 6Ribatti D, Nico B, Maxia C, et al. Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium[ J]. J Cell Mol Med, 2007, 11 (3) :585-589.
  • 7Huang C, Friend DS, Qiu WT, et al. Induction of a selective and persistent extravas ation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6[J]. J Immunol, 1998, 160(4) :1910-1919.
  • 8Blair R J, Meng H, Marchese MJ, et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor[ J ]. J Clin Invest, 1997,99 (11 ) :2691-2700.
  • 9Fineschi V, Monasterolo G, Rosi R. Fetal anaphylactic shock during a fluorescein angiography[J]. Forensic Sci Int, 1999,100 (1 -2) :137-142.
  • 10Ordoqui E, Zubeldia JM, Aranzabal A, et al. Serum tryptase levels in adverse drug reactions [J].Allergy, 1997,52 ( 11 ) : 1102- 1105.

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部